Growing Incidence of Infectious and Chronic Diseases Fueling the Demand for Rapid Medical Diagnostic Kits (RDKs) Reach $44 billion by 2030
Industry Experts, Inc released the latest version of the report on Rapid Medical Diagnostic Kits (RDKs). According to this new report, Rapid Medical Diagnostic Kits global market is estimated at US$26.4 billion in 2024 and projected to post a CAGR of 8.8% between 2024 and 2030 to reach US$43.7 billion in 2030.
The growth of the global rapid medical diagnostic kits market is fueled by the increasing incidence of infectious and chronic diseases such as HIV, tuberculosis, hepatitis, and diabetes, which is significantly increasing demand for early and accurate diagnosis. Public health programs and government initiatives are promoting early disease detection, while regulatory approvals for point-of-care and home-based diagnostic kits are accelerating the adoption of rapid diagnostic kits. Technological advancements, particularly in lateral flow assays, AI-integrated testing solutions, and smartphone-enabled diagnostics, have improved accuracy, affordability, and accessibility.
The Professional Kits segment holds the largest share in the global rapid medical diagnostic kits market by product, with an estimated 59.4% share in 2024. This dominance is attributed to their high sensitivity, specificity, and reliability in clinical settings. Healthcare professionals widely use these kits in hospitals, clinics, and diagnostic labs to detect various medical conditions, such as infectious diseases, diabetes, and heart-related issues. They were especially significant during the COVID-19 pandemic, as many governments approved only professional kits for accurate detection.
The market for RDKs is analyzed in this report on a global basis and the major regions covered include North America (The United States, Canada, and Mexico), Europe (Germany, France, the United Kingdom, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World.
The study analyzes the market for RDKs based on Products – Over-the-Counter (OTC) Kits and Professional Kits; Technologies – Lateral Flow, Solid-Phase, Agglutination and Flow-Through; Applications – Infectious Disease Testing, Blood Glucose Testing, Cardiometabolic Testing, Pregnancy & Fertility Testing, Fecal Occult Blood Testing, Coagulation Testing, Toxicology Testing, Lipid Profile Testing and Other Applications (Including Urinalysis, Allergy Testing, and others); End-user Facility – Hospitals & Clinics, Home Care Settings, Diagnostic Laboratories and Other End-Users (Including Pharmacies, Ambulatory Surgical Centers, and Research Institutes).
About Industry Experts, Inc.
Industry Experts, Inc., ranks among the leading market research providers globally. The company's off-the-shelf and customized business intelligence reports offer strategic insights and valuable guidance to enable various stakeholders, such as corporate strategists, analysts, researchers and startups, among others, in obtaining valuable, crisp and unbiased current and future market data. For more information, contact us on +1-320-497-3787 or visit https://industry-experts.com/
Comments
Post a Comment